Steven Wilson, M.D.

Steven E. Wilson, MD, received a bachelor’s degree in biology from California State University Fullerton and a master’s degree in molecular biology and biochemistry (Irvine) and an MD (San Diego) from the University of California.

His postgraduate training included an internship in internal medicine at Cedars-Sinai Medical Center in Los Angeles, and residency in ophthalmology at the Mayo Clinic. In addition, Wilson has held faculty positions at the University of Texas Southwestern in Dallas, Cleveland Clinic, and the University of Washington in Seattle, where he was Chair of Ophthalmology and Grace E Hill Professor in Ophthalmology and Biological Structure until 2003. He is currently Staff Refractive and Corneal Surgeon and Director of Corneal Research at the Cole Eye Institute at Cleveland Clinic.

Dr. Wilson has received numerous awards from the medical community, including being listed in "The Best Doctors of America" numerous times. He was an RPB William and Mary Greve International Research Scholar and received the Manpower Award from the Research to Prevent Blindness, a RPB Physician-Scientist Award, the Senior Honor Award from the American Academy of Ophthalmology, and he was elected to the honorary American Ophthalmological Society. He is a diplomat of the American Board of Ophthalmology. Cataract and Refractive Surgery Today named him as one of the 50 most influential doctors in cataract and refractive surgery in May 2006. He received the Lans Distinguished Lecturer Award from the International Society of Refractive Surgery-American Academy of Ophthalmology in 2006.

Wilson has edited many medical journals and papers, held national and international committee responsibilities under the auspices of organizations such as the National Institutes of Health, the Eye Bank Association of America, and Fight for Sight. He is a former trustee and vice president for the Association for Research in Vision and Ophthalmology (ARVO) the largest vision research organization in the world and served on the executive board for ISRS-AAO and is the program chairman for ISRS-AAO for 2006.

Wilson holds various medical patents; is a highly trained and skilled scientist and surgeon; has been awarded numerous research grants in the field of ophthalmology and vision research; and he has authored and presented more than 200 papers, medical books and book chapters. His research focuses on gene delivery to human cells using viral vectors, wound healing, and cytokines and receptors in eye tissues and breast tissues. His laboratory is funded by the National Eye Institute. He is also a leading expert in Dry Eye and Ocular Surface and helped design and implement the phase III clinical trial for topical cyclosporine for dry eye.

Dr. Wilson was selected as a finalist for the Benjamin Franklin Award for 2004 in the category Best New Voice in Fiction for his first international thriller Winter in Kandahar. His second international thriller, Ascent from Darkness, was released September 1, 2007 and was an honoree at the New York Book Festival and Hollywood Book Festival in 2007.

• NIH, NEI EY10056 RO1 grant Corneal Epithelial Growth Factors and Receptors, 1993 to 2010
• Physician-scientist Award, 2007, Research to Prevent Blindness, New York, NY
• Lans Distinguished Lecturer Award, International Society of Refractive Surgery-American Academy of Ophthalmology, 2006
• Association for Research in Vision and Ophthalmology (ARVO), Elected to Board of Trustees Cornea Section Representative (2001-2006), Vice-President (2005-2006)
• Best Doctors in America (2003-2008)

Laser Refractive Procedures (LASIK/PRK), Refractive Surgery.

• Research to Prevent Blindness William and Mary Greve International Research Scholar (July 1, 1992– February 1, 1994)
• Manpower Award, Research to Prevent Blindness (July 1, 1994-June 30, 1995)
• Honor Award, American Academy of Ophthalmology (1995)
• Everett-Kinsey Lecturer for 1998 CLAO Meeting
• Chancellor’s Award in Neuroscience & Eye Research, Louisiana State University Health Sciences Center, School of Medicine, New Orleans, La. (September 2000)
• Association for Research in Vision and Ophthalmology (ARVO), Elected to Board of Trustees Cornea Section Representative (2001-2006), Vice-President (2005-2006)
• Irvine Memorial Lecture. Doheny Eye Institute Annual Meeting, May, 2002, Los Angeles, Calif.
• American Academy of Ophthalmology, Executive Board, ISRS-AAO, 2001  to 2006
• Elected to American Ophthalmological Society, 2002
• Senior Honor Award, American Academy of Ophthalmology, 2004
• America’s Top Doctors, 2004-2008, Castle Connolly Guides, top 1% of medical specialists in America
• Best Doctors in America (2003-2008)
• 50 Most Influential Doctors, Cataract and Refractive Surgery Today, May, 2006
• Lans Distinguished Lecturer Award, International Society of Refractive Surgery-American Academy of Ophthalmology, 2006
• Distinguished Service Award, Association for Research in Vision and Ophthalmology, 2007
• Physician-scientist Award, 2007, Research to Prevent Blindness, New York, NY
• Horizons Grant Award, 2007
• NIH, NEI EY10056 RO1 grant Corneal Epithelial Growth Factors and Receptors, 1993 to 2010

• American Academy of Ophthalmology
• American Ophthalmological Society
• Association for Research in Vision and Ophthalmology
• International Society for Refractive Surgery
• International Society for Eye Research

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 8/4/2008, Dr. Wilson has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting.  Dr. Wilson receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:

• Allergan Medical

( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)